Last quarter (Q ), CervoMed's total revenue was $5.62M, an increase of Infinity% from the same quarter last year. In Q, CervoMed's net income was $1.88M. See CervoMed’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 7.14M	$ 7.14M	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 7.14M	$ 7.14M	-	-	-	-
Operating Expense	$ 6.43M	$ 14.96M	$ 15.97M	$ 16.04M	$ 15.97M	$ 11.55M
Operating Income	$ 719.67K	$ -7.81M	$ -15.97M	$ -16.04M	$ -15.97M	$ -11.55M
Net Non Operating Interest Income Expense	$ -128.36K	$ 219.43K	$ 380.75K	$ 137.49K	$ 114.26K	$ 85.30K
Other Income Expense	$ -5.42M	$ -5.42M	$ 35.64K	$ 8.64M	-	-
Pretax Income	$ 6.01M	$ -2.17M	$ -15.59M	$ -24.54M	$ -15.86M	$ -11.47M
Tax Provision	-	-	-	$ -443.89K	$ -1.68M	$ 332.88K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 6.01M	$ -2.17M	$ -15.59M	$ -24.10M	$ -16.14M	$ -11.80M
Basic EPS	$ 0.68	$ -0.82	$ -7.65	$ -12.50	$ -15.00	$ -1.76
Diluted EPS	$ 0.68	$ -0.82	$ -11.48	$ 4.88B	$ -15.00	$ -1.76
Basic Average Shares	$ 12.01M	$ 2.66M	$ 2.04M	$ 1.93M	$ 1.08M	$ 6.71M
Diluted Average Shares	$ 12.01M	$ 2.66M	$ -7.00	-	$ 1.08M	$ 6.71M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 6.43M	$ 14.96M	$ 15.97M	$ 16.04M	$ 15.97M	$ 11.55M
Net Income From Continuing And Discontinued Operation	$ -2.17M	$ -2.17M	$ -15.59M	$ -24.10M	$ -14.19M	$ -11.80M
Normalized Income	$ 3.19M	$ -1.72M	$ -12.32M	-	$ -14.19M	$ -11.80M
Interest Expense	-	-	-	-	-	-
EBIT	$ 6.01M	$ -2.17M	$ -15.59M	$ -24.54M	$ -15.97M	$ -11.55M
EBITDA	$ 6.01M	$ -2.17M	$ -15.59M	$ -24.45M	$ -15.87M	$ -11.45M

Currency in USD

CervoMed Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing